Ho-Joon Lee1, Sol A Seo2, Kang Min Park3. 1. Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea. 2. Department of Biomedical Engineering, Inje University, Gimhae, South Korea. 3. Department of Neurology Haeundae Paik Hospital, Inje University College of Medicine, Haeundae-ro 875, Haeundae-gu, Busan, 48108, South Korea. smilepkm@hanmail.net.
Abstract
PURPOSE: The aim of this study is to investigate the changes in the volume of individual thalamic nuclei in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS). METHODS: We enrolled 80 TLE patients with HS and 40 healthy controls. All of the subjects underwent 3D T1-weighted imaging. The hippocampus subfields and thalamic nuclei were segmented using the FreeSurfer program. We investigated volume changes in thalamic nuclei according to the HS side involved, and types or antiepileptic drug (AED) response compared with healthy controls. RESULTS: Compared with healthy controls, patients with HS showed atrophy of thalamic nuclei involving right and left parafascicular nuclei. In the right HS, the atrophy of the right thalamic nucleus was more prominent than that of the left thalamic nucleus, whereas the reduction in the volume of left thalamic nuclei was more prominent in patients with left HS. The reduction in thalamic nuclear volumes was more prominent in HS type 1 (atrophy of both CA1 and CA4 regions) than in other HS types. The suprageniculate nuclear volumes were significantly increased in patients with drug-controlled epilepsy. CONCLUSIONS: Our study demonstrates thalamic nuclear atrophy in TLE patients with HS. In addition, the atrophy of individual thalamic nuclei varied according to the HS side, the HS types, and the AED response. These findings suggest that the role of thalamic nuclei varied in TLE with HS subtypes and displayed varying degrees of vulnerability in the pathology networks associated with the hippocampus.
PURPOSE: The aim of this study is to investigate the changes in the volume of individual thalamic nuclei in patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS). METHODS: We enrolled 80 TLEpatients with HS and 40 healthy controls. All of the subjects underwent 3D T1-weighted imaging. The hippocampus subfields and thalamic nuclei were segmented using the FreeSurfer program. We investigated volume changes in thalamic nuclei according to the HS side involved, and types or antiepileptic drug (AED) response compared with healthy controls. RESULTS: Compared with healthy controls, patients with HS showed atrophy of thalamic nuclei involving right and left parafascicular nuclei. In the right HS, the atrophy of the right thalamic nucleus was more prominent than that of the left thalamic nucleus, whereas the reduction in the volume of left thalamic nuclei was more prominent in patients with left HS. The reduction in thalamic nuclear volumes was more prominent in HS type 1 (atrophy of both CA1 and CA4 regions) than in other HS types. The suprageniculate nuclear volumes were significantly increased in patients with drug-controlled epilepsy. CONCLUSIONS: Our study demonstrates thalamic nuclear atrophy in TLEpatients with HS. In addition, the atrophy of individual thalamic nuclei varied according to the HS side, the HS types, and the AED response. These findings suggest that the role of thalamic nuclei varied in TLE with HS subtypes and displayed varying degrees of vulnerability in the pathology networks associated with the hippocampus.
Authors: T E J Behrens; H Johansen-Berg; M W Woolrich; S M Smith; C A M Wheeler-Kingshott; P A Boulby; G J Barker; E L Sillery; K Sheehan; O Ciccarelli; A J Thompson; J M Brady; P M Matthews Journal: Nat Neurosci Date: 2003-07 Impact factor: 24.884
Authors: Jason H Su; Francis T Thomas; Willard S Kasoff; Thomas Tourdias; Eun Young Choi; Brian K Rutt; Manojkumar Saranathan Journal: Neuroimage Date: 2019-03-17 Impact factor: 6.556
Authors: K M Park; S E Kim; K J Shin; S Y Ha; J Park; T H Kim; C W Mun; B I Lee; S E Kim Journal: Acta Neurol Scand Date: 2016-08-24 Impact factor: 3.209
Authors: Juan Eugenio Iglesias; Ricardo Insausti; Garikoitz Lerma-Usabiaga; Martina Bocchetta; Koen Van Leemput; Douglas N Greve; Andre van der Kouwe; Bruce Fischl; César Caballero-Gaudes; Pedro M Paz-Alonso Journal: Neuroimage Date: 2018-08-17 Impact factor: 6.556
Authors: Kristin E Wills; Hernán F J González; Graham W Johnson; Kevin F Haas; Victoria L Morgan; Saramati Narasimhan; Dario J Englot Journal: Epilepsy Behav Date: 2020-12-15 Impact factor: 2.937
Authors: Yachin Chen; Nicholas Fallon; Barbara A K Kreilkamp; Christine Denby; Martyn Bracewell; Kumar Das; Emily Pegg; Rajiv Mohanraj; Anthony G Marson; Simon S Keller Journal: Hum Brain Mapp Date: 2021-08-25 Impact factor: 5.038
Authors: Philipp G Sämann; Juan Eugenio Iglesias; Boris Gutman; Dominik Grotegerd; Ramona Leenings; Claas Flint; Udo Dannlowski; Emily K Clarke-Rubright; Rajendra A Morey; Theo G M van Erp; Christopher D Whelan; Laura K M Han; Laura S van Velzen; Bo Cao; Jean C Augustinack; Paul M Thompson; Neda Jahanshad; Lianne Schmaal Journal: Hum Brain Mapp Date: 2020-12-27 Impact factor: 5.038